Volume 123, Issue 1 , Pages 224-230.e4, January 2009
Toll-like receptor 7–induced naive human B-cell differentiation and immunoglobulin production
Background
Toll-like receptors contribute to the establishment of adaptive immune responses.
Objective
The reported studies were conducted to examine the effects of the Toll-like receptor (TLR)–7 ligand, resiquimod, on human naive B-cell differentiation.
Methods
Naive human B cells were cultured with resiquimod in the presence or absence of IL-2 and IL-10. Secreted IgM and IgG were measured by ELISA, and IL-6, IL-10, and IFN-α were measured by a multiplex protein array. Cell proliferation was assessed by measuring [3H]thymidine uptake. mRNA for activation-induced cytidine deaminase and Iγ1-Cμ circle transcripts was measured by means of RT-PCR.
Results
Resiquimod induced the production of IgM and, to a lesser extent, IgG by naive human B cells in association with the secretion of IL-6 and IL-10, and a weak proliferative response. IL-2 and IL-10 synergized with resiquimod in markedly augmenting resiquimod-induced IgM and IgG production and proliferation. Resiquimod also stimulated production of IgG by B cells isolated from the blood of a patient with the X-linked hyper-IgM syndrome, with a greater response when these cells were costimulated with IL-2 and IL-10. The stimulated naive B cells from healthy volunteers displayed molecular evidence of immunoglobulin class-switch recombination—namely the appearance of activation-induced cytidine deaminase and Iγ1-Cμ circle transcripts.
Conclusion
Perturbation of TLR-7 on naive human B cells can lead to the induction of immunoglobulin class switch and IgG production in the absence of B-cell receptor cross-linking and CD40-CD40L interaction. The results are relevant to vaccine development and mechanisms by which microbial infection may lead to autoimmunity.
Key words: TLR-7, resiquimod, naive human B cells, immunoglobulin class-switch recombination, X-linked hyper-IgM syndrome
Abbreviations used: AID, Activation-induced cytidine deaminase, APC, Allophycocyanin, BAFF, B cell–activating factor of TNF family, BCR, B-cell receptor, CSR, Class-switch recombination, FITC, Fluorescein isothiocyanate, pDC, Plasmacytic dendritic cell, SIgG, Surface IgG, TLR, Toll-like receptor
Supported by the Immunology Research Fund, University of Pennsylvania School of Medicine.
Disclosure of potential conflict of interest: A. I. Levinson has consulting arrangements with Talecris and Baxter, has received research support from Novartis and the National Institutes of Health, and has served as an expert witness in vaccine injury litigation. C. H. Pletcher has served as a member of the International Society for the Advancement of Cytometry and the Great Lakes Imaging and Flow Cytometry Association. The rest of the authors have declared that they have no conflict of interest.
PII: S0091-6749(08)01681-3
doi:10.1016/j.jaci.2008.09.018
© 2009 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.
Volume 123, Issue 1 , Pages 224-230.e4, January 2009
